Please login to the form below
Alecensa
This page shows the latest Alecensa news and features for those working in and with pharma, biotech and healthcare.
Pfizer claims rapid FDA nod for Lorbrena
Lorbrena can also be used in patients who have seen disease progression on Roche’s Alecensa and Novartis’ Zykadia.
Latest news
-
Ocrevus surge keeps Roche smiling in Q3
However, the performance of Ocrevus and other drugs such as HER2 breast cancer therapy Perjeta (pertuzumab) and lung cancer therapy Alecensa (alectinib) – plus a strong showing in Asia-Pacific markets led
-
Roche’s Alecensa backed by China’s National Drug Administration
of that is Swiss drug maker Roche, which today received an approval to market its lung cancer treatment Alecensa in the country. ... Alecensa is now approved in over 57 countries as a first-line treatment for ALK-positive NSCLC.
-
Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland
Roche’s Alecensa approved by Scottish Medicines Consortium. Patients in Scotland with untreated, advanced non-small-cell lung cancer (NSCLC) with ALK-positive tumours have a new treatment option available via ... Alecensa is challenging Pfizer’s
-
Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down
Strong launches for new medicines Ocrevus, Tecentriq and Alecensa, especially in Germany, partially offset the loss in Europe.
-
Daily Brief: Health and social care still divided, Opdivo rejected in bladder cancer, Xalkori extends reach
Xalkori is for now keeping one step ahead of rival treatments, such as Novartis’ Zykadia, which gained NICE approval for use in ALK+ patients in January, and Roche’s Alecensa, which
More from news
Approximately 16 fully matching, plus 19 partially matching documents found.
Featured jobs
-
Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
-
Business Director
-
Competitive Salary Offered
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
